A PYMNTS Company

France: Millions in fines for pharma co’s ‘smear campaign’ against generics

By  |  May 14, 2013

More than $50 million in fines has been issued to drug giant Sanofi by France’s Antitrust Authority for what the regulator called a ‘smear campaign’ by the pharmaceutical company against generics drugs. Reports say the Authority found that Sanofi hampered competition by encouraging doctors and pharmacies to provide its brand name blood thinner drug Plavix instead of the generic form. Sanofi said it will appeal the fine. According to reports, Sanofi has looked to up profits since patent protection ended for two of its top-earning drugs, Plavix and blook pressure drug Avapro.

Full Content: Fox Business

Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.